(actualizado en diciembre de 2014).
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
Health Evidence Network synthesis report 53
This guidance is intended for use in developing standalone TB strategic plans, or TB interventions as part of multidisease or health sector plans. It describes key considerations and steps for strategic planning for TB in line with the World Health Organization’s End TB strategy, and the proposed ...structure of the NSP. The target audience of this publication are all stakeholders involved in national strategic planning for TB (e.g., ministry of health, other government ministries, private sector, civil society, affected communities, academic and research institutions, and technical and funding partners).
The current document is an update to the 2015 Toolkit to develop a national strategic plan for TB prevention, care and control.
more
Towards ending tuberculosis and multidrug-resistant tuberculosis.
Update 2021; Immunization, Vaccines and Biologicals
Consenso de los Laboratorios Supranacionales (LSN), Centros Colaboradores (CC) y Laboratorios Nacionales de Referencia (LNR) de “países priorizados” para la aplicación del Xpert-MTB/Rif en Las Américas.
Guatemala, 11-12 abril de 2011
Accessed December 2017
Regional Tuberculosis Program, Pan American Health Organization (PAHO/WHO)
Copenhagen, Denmark, 24–25 August 2017
Copenhagen, Denmark, 7–8 March 2017. Meeting report